The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys
- 1 April 1997
- Vol. 20 (4) , 355-364
- https://doi.org/10.1016/s8756-3282(97)00008-2
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Effects of dihydrotestosterone alone and combined with estrogen on bone mineral density, bone growth, and formation rates in ovariectomized ratsBone, 1996
- Effects of Androgens on Coronary Artery Atherosclerosis and Atherosclerosis-Related Impairment of Vascular ResponsivenessArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: Influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatmentCalcified Tissue International, 1993
- Factors affecting the assay of urinary 3–hydroxy pyridiniurn crosslinks of collagen as markers of bone resorptionEuropean Journal of Clinical Investigation, 1993
- Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis?Bone and Mineral, 1992
- Estimated intracortical bone turnover in the femur of growing macaques: Implications for their use as models in skeletal pathologyThe Anatomical Record, 1992
- Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: Comparison with normal postmenopausal womenOsteoporosis International, 1990
- Effect of Excess Endogenous Androgens on Bone Density in Young WomenJournal of Clinical Endocrinology & Metabolism, 1988
- Active Bone Turnover of the Cortico-Endosteal Envelope in Postmenopausal Osteoporosis*Journal of Clinical Endocrinology & Metabolism, 1987
- Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal maleCalcified Tissue International, 1978